| 【Company Research】Nongfu Spring (9633 HK) - FY25: Strong tea & juice biz; facing challenges to maintain high growth |
| 【Company Research】CSPC Pharmaceutical (1093 HK) - BD becoming sustainable revenue engine |
| 【Company Research】Kuaishou (1024 HK) - Solid AI monetization progress; increasing AI investment may impact ST margin |
| 【Company Research】WuXi XDC (2268 HK) - Ambitious capacity expansion to continue |
| 【Company Research】WuXi AppTec (603259 CH) - Strong CDMO demand to fuel 2026 growth |
| 【Company Research】Xiaomi (1810 HK) - 4Q25 better than feared; Positive on AI investment to bear fruit in 2026-27 |
| 【Company Research】Tongcheng Travel (780 HK) - Expecting resilient core business earnings growth in 2026 |
| 【Company Research】SenseTime (20 HK) - FY25 results beat on solid Gen AI business and enhanced operating efficiency |
| 【Company Research】Kelun-Biotech (6990 HK) - Inaugural year of commercialization |
| 【Company Research】Minth Group (425 HK) - Solid outlook in both auto and new businesses |
公司地址：香港中環花園道三號冠君大廈45-46樓
電話：（852） 3900-0888 傳真：（852） 3761-8788
招銀國際版權所有 Copyright © 2019-2026 CMB International Capital Corporation Limited. All rights reserved.
